Laboratory Medicine ›› 2022, Vol. 37 ›› Issue (7): 641-645.DOI: 10.3969/j.issn.1673-8640.2022.07.009
Previous Articles Next Articles
XU Qianqian, JIANG Wangqing, SHEN Linjie, LU Yingjie, CHEN Jian, JIANG Haoqin()
Received:
2020-10-09
Revised:
2021-04-27
Online:
2022-07-30
Published:
2022-08-26
Contact:
JIANG Haoqin
CLC Number:
XU Qianqian, JIANG Wangqing, SHEN Linjie, LU Yingjie, CHEN Jian, JIANG Haoqin. Establishment of the reference intervals for related parameters of adult reticulocytes in Shanghai[J]. Laboratory Medicine, 2022, 37(7): 641-645.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2022.07.009
项目 | M(P25,P75) | 偏度系数 | 峰度系数 | P值 |
---|---|---|---|---|
RET% | 1.45(1.22,1.66) | 0.474 | 0.456 | 0.000 |
RET# | 69.00(57.45,81.40) | 0.259 | -0.277 | 0.000 |
IRF% | 8.80(6.90,10.80) | 1.101 | 2.66 | 0.000 |
LFR% | 91.20(89.20,93.10) | -1.101 | 2.66 | 0.000 |
MFR% | 7.70(6.10,9.30) | 0.358 | 0.177 | 0.000 |
HFR% | 1.10(0.70,1.50) | 3.321 | 14.114 | 0.000 |
Ret-He | 32.80(31.90,33.60) | -1.268 | 5.365 | 0.000 |
RPI | 1.30(1.00,1.70) | 0.377 | -0.479 | 0.000 |
项目 | M(P25,P75) | 偏度系数 | 峰度系数 | P值 |
---|---|---|---|---|
RET% | 1.45(1.22,1.66) | 0.474 | 0.456 | 0.000 |
RET# | 69.00(57.45,81.40) | 0.259 | -0.277 | 0.000 |
IRF% | 8.80(6.90,10.80) | 1.101 | 2.66 | 0.000 |
LFR% | 91.20(89.20,93.10) | -1.101 | 2.66 | 0.000 |
MFR% | 7.70(6.10,9.30) | 0.358 | 0.177 | 0.000 |
HFR% | 1.10(0.70,1.50) | 3.321 | 14.114 | 0.000 |
Ret-He | 32.80(31.90,33.60) | -1.268 | 5.365 | 0.000 |
RPI | 1.30(1.00,1.70) | 0.377 | -0.479 | 0.000 |
性别 | 例数 | RET%/% | RET#/(×109/L) | IRF%/% | LFR%/% |
---|---|---|---|---|---|
男性 | 1 059 | 1.49(1.28,1.67) | 75.60(63.90,85.55) | 9.1(7.2,11.0) | 90.9(89.0,92.9) |
女性 | 1 021 | 1.39(1.19,1.65) | 62.60(52.50,75.00) | 8.5(6.6,10.6) | 91.5(89.4,93.4) |
Z值 | -4.725 | -15.088 | -4.148 | -4.148 | |
P值 | 0.000 | 0.000 | 0.000 | 0.000 | |
性别 | MFR%/% | HFR%/% | RET-He/pg | RPI | |
男性 | 7.9(6.4,9.5) | 1.1(0.7,1.6) | 33.2(32.3,34.0) | 1.6(1.3,1.9) | |
女性 | 7.5(5.9,9.1) | 1.0(0.6,1.5) | 32.4(31.5,33.2) | 1.1(0.9,1.3) | |
Z值 | -4.035 | -3.274 | -13.172 | -26.922 | |
P值 | 0.000 | 0.001 | 0.000 | 0.000 |
性别 | 例数 | RET%/% | RET#/(×109/L) | IRF%/% | LFR%/% |
---|---|---|---|---|---|
男性 | 1 059 | 1.49(1.28,1.67) | 75.60(63.90,85.55) | 9.1(7.2,11.0) | 90.9(89.0,92.9) |
女性 | 1 021 | 1.39(1.19,1.65) | 62.60(52.50,75.00) | 8.5(6.6,10.6) | 91.5(89.4,93.4) |
Z值 | -4.725 | -15.088 | -4.148 | -4.148 | |
P值 | 0.000 | 0.000 | 0.000 | 0.000 | |
性别 | MFR%/% | HFR%/% | RET-He/pg | RPI | |
男性 | 7.9(6.4,9.5) | 1.1(0.7,1.6) | 33.2(32.3,34.0) | 1.6(1.3,1.9) | |
女性 | 7.5(5.9,9.1) | 1.0(0.6,1.5) | 32.4(31.5,33.2) | 1.1(0.9,1.3) | |
Z值 | -4.035 | -3.274 | -13.172 | -26.922 | |
P值 | 0.000 | 0.001 | 0.000 | 0.000 |
组别 | 例数 | RET%/% | RET#/(×109/L) | IRF%/% | LFR%/% |
---|---|---|---|---|---|
18~40岁组 | 1 084 | 1.43(1.21,1.65) | 68.70(56.75,81.75) | 8.4(6.5,10.3) | 91.6(89.7,93.5) |
41~60岁组 | 823 | 1.46(1.24,1.67) | 70.20(58.30,81.45) | 9.3(7.4,11.1)* | 90.7(88.9,90.6)* |
61~80岁组 | 173 | 1.47(1.22,1.67) | 67.90(58.80,79.20) | 9.3(7.3,11.4)* | 90.7(88.6,92.7)* |
H值 | 4.248 | 1.997 | 40.915 | 40.915 | |
P值 | 0.120 | 0.368 | 0.000 | 0.000 | |
组别 | MFR%/% | HFR%/% | RET-He/pg | RPI | |
18~40岁组 | 7.3(5.8,9.1) | 1.0(0.6,1.4) | 32.6(31.8,33.5) | 1.3(1.0,1.7) | |
41~60岁组 | 8.0(6.5,9.4)* | 1.2(0.8,1.7)* | 32.9(32.0,33.7)* | 1.3(1.0,1.7) | |
61~80岁组 | 8.2(6.4,9.9)* | 1.2(0.8,1.8)* | 33.0(32.1,33.9)* | 1.3(1.1,1.7) | |
H值 | 34.341 | 39.27 | 28.938 | 3.146 | |
P值 | 0.000 | 0.000 | 0.000 | 0.207 |
组别 | 例数 | RET%/% | RET#/(×109/L) | IRF%/% | LFR%/% |
---|---|---|---|---|---|
18~40岁组 | 1 084 | 1.43(1.21,1.65) | 68.70(56.75,81.75) | 8.4(6.5,10.3) | 91.6(89.7,93.5) |
41~60岁组 | 823 | 1.46(1.24,1.67) | 70.20(58.30,81.45) | 9.3(7.4,11.1)* | 90.7(88.9,90.6)* |
61~80岁组 | 173 | 1.47(1.22,1.67) | 67.90(58.80,79.20) | 9.3(7.3,11.4)* | 90.7(88.6,92.7)* |
H值 | 4.248 | 1.997 | 40.915 | 40.915 | |
P值 | 0.120 | 0.368 | 0.000 | 0.000 | |
组别 | MFR%/% | HFR%/% | RET-He/pg | RPI | |
18~40岁组 | 7.3(5.8,9.1) | 1.0(0.6,1.4) | 32.6(31.8,33.5) | 1.3(1.0,1.7) | |
41~60岁组 | 8.0(6.5,9.4)* | 1.2(0.8,1.7)* | 32.9(32.0,33.7)* | 1.3(1.0,1.7) | |
61~80岁组 | 8.2(6.4,9.9)* | 1.2(0.8,1.8)* | 33.0(32.1,33.9)* | 1.3(1.1,1.7) | |
H值 | 34.341 | 39.27 | 28.938 | 3.146 | |
P值 | 0.000 | 0.000 | 0.000 | 0.207 |
性别 | 例数 | IRF%/% | LFR%/% | MFR%/% | HFR%/% | RET-He/pg |
---|---|---|---|---|---|---|
男性 | 518 | 8.8(6.8,10.7) | 91.2(89.3,93.2) | 7.7(6.2,9.4) | 1.1(0.7,1.5) | 32.9(32.0,33.7) |
女性 | 566 | 7.9(6.2,10.0) | 92.1(90.0,93.8) | 7.0(5.6,8.7) | 0.9(0.6,1.4) | 32.4(31.6,33.1) |
Z值 | -4.133 | -4.133 | -4.066 | -3.197 | -6.878 | |
P值 | 0.000 | 0.000 | 0.000 | 0.001 | 0.000 |
性别 | 例数 | IRF%/% | LFR%/% | MFR%/% | HFR%/% | RET-He/pg |
---|---|---|---|---|---|---|
男性 | 518 | 8.8(6.8,10.7) | 91.2(89.3,93.2) | 7.7(6.2,9.4) | 1.1(0.7,1.5) | 32.9(32.0,33.7) |
女性 | 566 | 7.9(6.2,10.0) | 92.1(90.0,93.8) | 7.0(5.6,8.7) | 0.9(0.6,1.4) | 32.4(31.6,33.1) |
Z值 | -4.133 | -4.133 | -4.066 | -3.197 | -6.878 | |
P值 | 0.000 | 0.000 | 0.000 | 0.001 | 0.000 |
性别 | 例数 | IRF%/% | LFR%/% | MFR%/% | HFR%/% | RET-He/pg |
---|---|---|---|---|---|---|
男性 | 541 | 9.4(7.6,11.3) | 90.6(88.7,92.4) | 8.1(6.7,9.6) | 1.2(0.8,1.7) | 33.4(32.5,34.1) |
女性 | 455 | 9.2(7.2,11.0) | 90.8(89.0,92.8) | 8.0(6.4,9.4) | 1.2(0.7,1.7) | 32.4(31.5,33.3) |
Z值 | -1.187 | -1.187 | -1.081 | -0.901 | -11.347 | |
P值 | 0.235 | 0.235 | 0.280 | 0.368 | 0.000 |
性别 | 例数 | IRF%/% | LFR%/% | MFR%/% | HFR%/% | RET-He/pg |
---|---|---|---|---|---|---|
男性 | 541 | 9.4(7.6,11.3) | 90.6(88.7,92.4) | 8.1(6.7,9.6) | 1.2(0.8,1.7) | 33.4(32.5,34.1) |
女性 | 455 | 9.2(7.2,11.0) | 90.8(89.0,92.8) | 8.0(6.4,9.4) | 1.2(0.7,1.7) | 32.4(31.5,33.3) |
Z值 | -1.187 | -1.187 | -1.081 | -0.901 | -11.347 | |
P值 | 0.235 | 0.235 | 0.280 | 0.368 | 0.000 |
性别 | RET%/% | RET#/(×109/L) | RPI |
---|---|---|---|
男性 | 0.92~2.15 | 46.30~107.30 | 0.9~2.4 |
女性 | 0.87~2.27 | 37.96~101.90 | 0.6~1.8 |
性别 | RET%/% | RET#/(×109/L) | RPI |
---|---|---|---|
男性 | 0.92~2.15 | 46.30~107.30 | 0.9~2.4 |
女性 | 0.87~2.27 | 37.96~101.90 | 0.6~1.8 |
项目 | IRF%/% | LFR%/% | MFR%/% | HFR%/% | RET-He/pg |
---|---|---|---|---|---|
18~40岁 | |||||
男性 | 4.1~16.1 | 83.9~96.0 | 3.6~12.1 | 0.2~5.0 | 30.3~35.5 |
女性 | 3.9~17.9 | 82.1~96.1 | 3.6~12.5 | 0.1~5.5 | 27.6~34.6 |
41~80岁 | 4.4~18.0 | 82.0~95.6 | 4.0~12.8 | 0.2~5.1 | |
男性 | 30.4~35.7 | ||||
女性 | 27.8~34.6 |
项目 | IRF%/% | LFR%/% | MFR%/% | HFR%/% | RET-He/pg |
---|---|---|---|---|---|
18~40岁 | |||||
男性 | 4.1~16.1 | 83.9~96.0 | 3.6~12.1 | 0.2~5.0 | 30.3~35.5 |
女性 | 3.9~17.9 | 82.1~96.1 | 3.6~12.5 | 0.1~5.5 | 27.6~34.6 |
41~80岁 | 4.4~18.0 | 82.0~95.6 | 4.0~12.8 | 0.2~5.1 | |
男性 | 30.4~35.7 | ||||
女性 | 27.8~34.6 |
[1] |
HILLMAN R S. Characteristics of marrow production and reticulocyte maturation in normal man in response to anemia[J]. J Clin Invest, 1969, 48(3):443-453.
DOI URL |
[2] |
PIVA E, BRUGNARA C, SPOLAORE F, et al. Clinical utility of reticulocyte parameters[J]. Clin Lab Med, 2015, 35(1):133-163.
DOI URL |
[3] |
CAI J, WU M, REN J, et al. Evaluation of the efficiency of the reticulocyte hemoglobin content on diagnosis for iron deficiency anemia in Chinese adults[J]. Nutrients, 2017, 9(5):450.
DOI URL |
[4] | CANALS C, REMACHA A F, SARDÁ M P, et al. Clinical utility of the new Sysmex XE 2100 parameter-reticulocyte hemoglobin equivalent-in the diagnosis of anemia[J]. Haematologica, 2005, 90(8):1133-1134. |
[5] | BORBA R, LIMA C S, GROTTO H Z. Reticulocyte parameters and hemoglobin F production in sickle cell disease patients undergoing hydroxyurea therapy[J]. J Clin Lab Analy, 2003, 17(2):66-72. |
[6] |
FENDEL R, BRANDTS C, RUDAT A, et al. Hemolysis is associated with low reticulocyte production index and predicts blood transfusion in severe malarial anemia[J]. PLoS One, 2010, 5(4):e10038.
DOI URL |
[7] | PIVA E, BRUGNARA C, CHIANDETTI L, et al. Automated reticulocyte counting:state of the art and clinical applications in the evaluation of erythropoiesis[J]. Clin Chem Lab Med, 2010, 48(10):1369-1380. |
[8] |
IBÁÑEZ-ALCALDE M M, VÁZQUEZ-LÓPEZ M Á, RUÍZ-SÁNCHEZ A M, et al. Reference values of reticulocyte hemoglobin content in healthy adolescents[J]. J Pediatr Hematol Oncol, 2018, 40(4):298-303.
DOI URL |
[9] | 韩启福, 彭海, 李子安, 等. 西宁地区健康成人网织红细胞血红蛋白含量参考区间的建立与验证[J]. 国际检验医学杂志, 2020, 41(1):111-113. |
[10] | 李小龙, 陶洪群, 王薇薇, 等. 温州地区健康成人外周血网织红细胞血红蛋白及网织红分群值正常值范围调查[J]. 中华检验医学杂志, 2011, 34(2):147-151. |
[11] | 赵丽娟, 王言, 肖贺欣, 等. 长春地区网织红细胞血红蛋白含量参考区间的建立[J]. 中国实验诊断学, 2018, 22(9):1546-1548. |
[1] | AN Yinghong, YAO Kechun, SU Chengming, TANG Jinhua, YANG Lixin, GAO Jie, XU Yanting, YAN Qiuhong, ZHAN Hongyan, MA Yueyun. Survey of serum homocysteine levels of apparently healthy subjects in Beijing [J]. Laboratory Medicine, 2023, 38(11): 1036-1040. |
[2] | ZHAO Yanhong, FU Lin, LIU Biao, XIAO Meifang. Reference interval of lactate dehydrogenase among 3-14-year-old population in Hainan [J]. Laboratory Medicine, 2023, 38(11): 1041-1043. |
[3] | MIAO Linzi, LU Yao, QU Chenxue, YOU Ran, GONG Yan. Establishment of the reference intervals of leukocyte surface CD64 and HLA-DR indexes for healthy adults and related factors [J]. Laboratory Medicine, 2022, 37(3): 240-245. |
[4] | LU Youli, YANG Shuangshuang, ZHANG Meiwei, OU Meixian, DONG Chunxia, SHEN Weiwei, JIANG Fengli, LI Shuijun. Simultaneous determination of 5 steroid hormones in human serum by ultra-performance liquid chromatography-tandem mass spectrometry and establishment of reference intervals in healthy adults [J]. Laboratory Medicine, 2022, 37(2): 165-173. |
[5] | YU Jianhong, PENG Qingyuan, YIN Minggang. Establishment of reference intervals of serum PGⅠ,PGⅡ and PGR for apparently healthy subjects in Zigong [J]. Laboratory Medicine, 2022, 37(1): 23-27. |
[6] | LI Jing, QUAN Hui, ZENG Zhirong, WEI Yi. Establishment of the reference interval of small and dense low-density lipoprotein cholesterol in apparently healthy adults in Chengdu [J]. Laboratory Medicine, 2021, 36(6): 609-614. |
[7] | WANG Zipeng, OUYANG Changli, GENG Deqin, WANG Dunjing. Establishment of cerebrospinal fluid IL-6 reference interval in non-inflammatory central nervous system diseases [J]. Laboratory Medicine, 2021, 36(6): 627-630. |
[8] | YUE Bo, LI Danjie, TANG Dahai, LIU Manjiao, HE Jialei, JIANG Mengjie, WEI Xiaoqiang. Establishment of a new algorithm for the reference interval of relative change values and application evaluation [J]. Laboratory Medicine, 2021, 36(6): 667-673. |
[9] | JI Zhi, DENG Lingyan, LI Jiaoyuan, WANG Xu, LI Huijun, CHENG Liming. Reference interval establishment of serum cytokeratin 19 fragment for healthy adults in Wuhan [J]. Laboratory Medicine, 2021, 36(5): 490-494. |
[10] | LENG Deguo, YU Jinming, CAO Cheng, XU Hui. Clinical significance of reticulocyte parameters in acute pancreatitis [J]. Laboratory Medicine, 2021, 36(3): 296-299. |
[11] | ZOU Ning, CHEN Guangxi, MA Hua, Qiurang, Zhaxinamo. Survey on the reference intervals of venous blood cells among native Tibetan adults in Aba county [J]. Laboratory Medicine, 2021, 36(2): 198-201. |
[12] | AN Chongwen, LI Haixia, JIAO Lili. Establishment of reference interval for the detection of serum protein electrophoresis by V8 Nexus high speed automated capillary electrophoresis apparatus [J]. Laboratory Medicine, 2021, 36(1): 8-12. |
[13] | YUE Chaoyan, DUAN Chaohui, ZHANG Di, WEI Jie, LUO Xiaohong, ZHANG Qianlan, WU Yong, YING Chunmei. Performance evaluation of acridinium ester labeled direct chemiluminescence method for the detection of AMH and establishment of adult female AMH reference interval [J]. Laboratory Medicine, 2021, 36(1): 95-100. |
[14] | WU Qun, SHEN Junfei, WU Wenhao, WANG Beili, PAN Baishen, GUO Wei. Establishment of reference intervals of total bilirubin and direct bilirubin by indirect method [J]. Laboratory Medicine, 2020, 35(8): 749-752. |
[15] | DU Yuxuan, WANG Wei, HE Falin, ZHONG Kun, YUAN Shuai, LIU Jiali, ZHANG Zhixin, WANG Zhiguo. Investigation and analysis on pediatric reference intervals of routine chemistry items in China [J]. Laboratory Medicine, 2020, 35(7): 676-681. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||